Literature DB >> 15014615

A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary Care.

James C. Ballenger1, Jonathan R. T. Davidson, Yves Lecrubier, David J. Nutt.   

Abstract

The International Consensus Group on Depression and Anxiety has held 7 meetings over the last 3 years that focused on depression and specific anxiety disorders. During the course of the meeting series, a number of common themes have developed. At the last meeting of the Consensus Group, we reviewed these areas of commonality across the spectrum of depression and anxiety disorders. With the aim of improving the recognition and management of depression and anxiety in the primary care setting, we developed an algorithm that is presented in this article. We attempted to balance currently available scientific knowledge about the treatment of these disorders and to reformat it to provide an acceptable algorithm that meets the practical aspects of recognizing and treating these disorders in primary care.

Entities:  

Year:  2001        PMID: 15014615      PMCID: PMC181161          DOI: 10.4088/pcc.v03n0201

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  44 in total

Review 1.  Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.

Authors:  N S Gunasekara; S Noble; P Benfield
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

2.  Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study.

Authors:  K M Connor; S M Sutherland; L A Tupler; M L Malik; J R Davidson
Journal:  Br J Psychiatry       Date:  1999-07       Impact factor: 9.319

3.  Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group.

Authors:  D Baldwin; J Bobes; D J Stein; I Scharwächter; M Faure
Journal:  Br J Psychiatry       Date:  1999-08       Impact factor: 9.319

4.  A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.

Authors:  Y Lecrubier; A Bakker; G Dunbar; R Judge
Journal:  Acta Psychiatr Scand       Date:  1997-02       Impact factor: 6.392

5.  Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.

Authors:  M B Stein; A J Fyer; J R Davidson; M H Pollack; B Wiita
Journal:  Am J Psychiatry       Date:  1999-05       Impact factor: 18.112

6.  Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.

Authors:  J C Ballenger; D E Wheadon; M Steiner; W Bushnell; I P Gergel
Journal:  Am J Psychiatry       Date:  1998-01       Impact factor: 18.112

7.  Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study.

Authors:  R L Spitzer; K Kroenke; M Linzer; S R Hahn; J B Williams; F V deGruy; D Brody; M Davies
Journal:  JAMA       Date:  1995-11-15       Impact factor: 56.272

8.  EEG sleep in outpatients with generalized anxiety: a preliminary comparison with depressed outpatients.

Authors:  C F Reynolds; D H Shaw; T F Newton; P A Coble; D J Kupfer
Journal:  Psychiatry Res       Date:  1983-02       Impact factor: 3.222

9.  Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors.

Authors:  L C Barr; W K Goodman; C J McDougle; P L Delgado; G R Heninger; D S Charney; L H Price
Journal:  Arch Gen Psychiatry       Date:  1994-04

10.  The SDDS-PC: a diagnostic aid for multiple mental disorders in primary care.

Authors:  M Olfson; A C Leon; W E Broadhead; M M Weissman; J E Barrett; R S Blacklow; T T Gilbert; E S Higgins
Journal:  Psychopharmacol Bull       Date:  1995
View more
  12 in total

1.  Discrepancy in diagnosis and treatment of post-traumatic stress disorder (PTSD): treatment for the wrong reason.

Authors:  Ellen C Meltzer; Tali Averbuch; Jeffrey H Samet; Richard Saitz; Khelda Jabbar; Christine Lloyd-Travaglini; Jane M Liebschutz
Journal:  J Behav Health Serv Res       Date:  2012-04       Impact factor: 1.505

2.  Are anxiety and depression addressed in primary care patients with chronic obstructive pulmonary disease? A chart review.

Authors:  Kent Roundy; Jeffrey A Cully; Melinda A Stanley; Connie Veazey; Julianne Souchek; Nelda P Wray; Mark E Kunik
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

3.  Psychodynamic therapies versus other psychological therapies for depression.

Authors:  Rachel Churchill; Theresa Hm Moore; Philippa Davies; Deborah Caldwell; Hannah Jones; Glyn Lewis; Vivien Hunot
Journal:  Cochrane Database Syst Rev       Date:  2010

4.  Psychodynamic therapies versus treatment as usual for depression.

Authors:  Theresa Hm Moore; Vivien Hunot; Philippa Davies; Deborah Caldwell; Hannah Jones; Glyn Lewis; Rachel Churchill
Journal:  Cochrane Database Syst Rev       Date:  2010

5.  Humanistic therapies versus other psychological therapies for depression.

Authors:  Rachel Churchill; Philippa Davies; Deborah Caldwell; Theresa Hm Moore; Hannah Jones; Glyn Lewis; Vivien Hunot
Journal:  Cochrane Database Syst Rev       Date:  2010

6.  Interpersonal, cognitive analytic and other integrative therapies versus other psychological therapies for depression.

Authors:  Vivien Hunot; Theresa Hm Moore; Deborah Caldwell; Philippa Davies; Hannah Jones; Glyn Lewis; Rachel Churchill
Journal:  Cochrane Database Syst Rev       Date:  2010

7.  Humanistic therapies versus treatment as usual for depression.

Authors:  Philippa Davies; Vivien Hunot; Theresa Hm Moore; Deborah Caldwell; Hannah Jones; Glyn Lewis; Rachel Churchill
Journal:  Cochrane Database Syst Rev       Date:  2010

8.  Interpersonal, cognitive analytic and other integrative therapies versus treatment as usual for depression.

Authors:  Rachel Churchill; Philippa Davies; Deborah Caldwell; Theresa Hm Moore; Hannah Jones; Glyn Lewis; Vivien Hunot
Journal:  Cochrane Database Syst Rev       Date:  2010

9.  Cognitive behavioural therapies versus treatment as usual for depression.

Authors:  Vivien Hunot; Theresa Hm Moore; Deborah Caldwell; Philippa Davies; Hannah Jones; Toshi A Furukawa; Glyn Lewis; Rachel Churchill
Journal:  Cochrane Database Syst Rev       Date:  2010

10.  Cognitive behavioural therapies versus other psychological therapies for depression.

Authors:  Rachel Churchill; Theresa Hm Moore; Deborah Caldwell; Philippa Davies; Hannah Jones; Toshi A Furukawa; Glyn Lewis; Vivien Hunot
Journal:  Cochrane Database Syst Rev       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.